Uncategorized Royalty Pharma plc (RPRX) Completes $2B Senior Notes Offering, Strengthens Capital for Growth Post Content
Uncategorized Viatris Inc. (VTRS) Gains FDA Approval for First Generic Iron Sucrose Injection Post Content
Uncategorized Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies Post Content
Uncategorized EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela Post Content
Uncategorized Merck & Co., Inc. (MRK) Received FDA Approval For Keytruda Qlex, Cutting Infusion Time to 2 Minutes Post Content
Uncategorized Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis Post Content
Uncategorized Bristol-Myers Squibb Company (BMY) to Divest 60% China JV Amid Strategic Realignment Post Content
Uncategorized Retirement Fear Is Real: 64% Worry More About Running Out Of Money Than Death Itself Post Content